Paul R. Hansen, Director at Vyant Bio, Inc. (VYNT), bought 20,000 shares at $2.35 ($47K) on 2021-08-19, disclosed to the SEC on 2021-08-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.